Atlas Trials

Long-Term Follow-up Study

Clinical trial NCT05332054 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05332054
Sponsor
Caribou Biosciences, Inc.
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Lymphoma, Non-HodgkinRelapsed Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin LymphomaNon-Hodgkin LymphomaLymphomaB Cell LymphomaB-Cell Non-Hodgkin's LymphomaHematologic MalignancyRelapsed/Refractory Multiple MyelomaRelapsed/Refractory Acute Myeloid Leukemia
Start date
2022-03-16
Primary completion
2041-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.